Cancer-testis antigen expression in bladder cancer

Progres en Urologie

Volumn 15, Issue 6 SUPPL. 1, 2005, Pages 1303-1313

  Fradet, Yves ^a   Picard, V ^a   Bergeron, A ^a   LaRue, H ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bladder cancer; Cancer testis antigens; Immunotherapy; MAGE; NY ESO 1

Indexed keywords

TUMOR ANTIGEN;

ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; HUMAN; IMMUNOLOGY; MALE; METABOLISM; TESTIS TUMOR; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; HUMANS; MALE; TESTICULAR NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 33749064201     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AMLING, C.L.: Diagnosis and management of superficial bladder cancer. Curr.Probl.Cancer, 2001 ; 25 ; 219-278.
2. BAR-HAIM, E., PAZ, A., MACHLENKIN, A., HAZZAN, D., TIROSH, B., CARMON, L., BRENNER, B., VADAI, E., MOR, O., STEIN, A., LEMONNIER, F.A., TZEHOVAL, E., EISENBACH, L.: MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides. Br.J.Cancer, 2004 ; 91 ; 398-407.
3. BOEL, P., WILDMANN, C., SENSI, M.L., BRASSEUR, R., RENAULD, J.C., COULIE, P., BOON, T., VAN DER, B.P.: BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity., 1995 ; 2 ; 167-175.
4. CHRISTMAN, J.K.: 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene, 2002 ; 21 ; 5483-5495.
5. CORAL, S., SIGALOTTI, L., ALTOMONTE, M., ENGELSBERG, A., COLIZZI, F., CATTAROSSI, I., MARASKOVSKY, E., JAGER, E., SELIGER, B., MAIO, M.: 5-aza-2′-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin.Cancer Res., 2002 ; 8 ; 2690-2695.
6. CORAL, S., SIGALOTTI, L., GASPAROLLO, A., CATTAROSSI, I., VISINTIN, A., CATTELAN, A., ALTOMONTE, M., MAIO, M.: Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2′-deoxycytidine (5-AZA-CdR). J.Immunother., 1999 ; 22 ; 16-24.
7. COULIE, P.G., KARANIKAS, V., LURQUIN, C., COLAU, D., CONNEROTTE, T., HANAGIRI, T., VAN PEL, A., LUCAS, S., GODELAINE, D., LONCHAY, C., MARCHAND, M., VAN BAREN, N., BOON, T.: Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. Immunol.Rev., 2002 ; 188 ; 33-42.
8. GURE, A.O., WEI, I.J., OLD, L.J., CHEN, Y.T.: The SSX gene family: characterization of 9 complete genes. Int.J.Cancer, 2002 ; 101 ; 448-453.
9. JAGER, E., NAGATA, Y., GNJATIC, S., WADA, H., STOCKERT, E., KARBACH, J., DUNBAR, P.R., LEE, S.Y., JUNGBLUTH, A., JAGER, D., ARAND, M., RITTER, G., CERUNDOLO, V., DUPONT, B., CHEN, Y.T., OLD, L.J., KNUTH, A.: Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc.Natl.Acad.Sci.U.S.A, 2000 ; 97 ; 4760-4765.
10. JURETIC, A., SPAGNOLI, G.C., SCHULTZ-THATER, E., SARCEVIC, B.: Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies. Lancet Oncol., 2003 ; 4 ; 104-109.
11. KOCHER, T., ZHENG, M., BOLLI, M., SIMON, R., FORSTER, T., SCHULTZ-THATER, E., REMMEL, E., NOPPEN, C., SCHMID, U., ACKERMANN, D., MIHATSCH, M.J., GASSER, T., HEBERER, M., SAUTER, G., SPAGNOLI, G.C.: Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int.J.Cancer, 2002 ; 100 ; 702-705.
12. KURASHIGE, T., NOGUCHI, Y., SAIKA, T., ONO, T., NAGATA, Y., JUNGBLUTH, A., RITTER, G., CHEN, Y.T., STOCKERT, E., TSUSHIMA, T., KUMON, H., OLD, L.J., NAKAYAMA, E.: NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res., 2001 ; 61 ; 4671-4674.
13. LANDRY, C., BRASSEUR, F., SPAGNOLI, G.C., MARBAIX, E., BOON, T., COULIE, P., GODELAINE, D.: Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int.J.Cancer, 2000 ; 86 ; 835-841.
14. MARKS, P.A., RICHON, V.M., BRESLOW, R., RIFKIND, R.A.: Histone deacetylase inhibitors as new cancer drugs. Curr.Opin.Oncol., 2001 ; 13 ; 477-483.
15. PATARD, J.J., BRASSEUR, F., GIL-DIEZ, S., RADVANYI, F., MARCHAND, M., FRANCOIS, P., ABI-AAD, A., VAN CANGH, P., ABBOU, C.C., CHOPIN, D., .: Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int.J.Cancer, 1995 ; 64 ; 60-64.
16. SCANLAN, M.J., SIMPSON, A.J., OLD, L.J.: The cancer/testis genes: review, standardization, and commentary. Cancer Immun., 2004 ; 4 ; 1-
17. SHARMA, P., GNJATIC, S., JUNGBLUTH, A.A., WILLIAMSON, B., HERR, H., STOCKERT, E., DALBAGNI, G., DONAT, S.M., REUTER, V.E., SANTIAGO, D., CHEN, Y.T., BAJORIN, D.F., OLD, L.J.: Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer Immun., 2003 ; 3 ; 19-
18. STOCKERT, E., JAGER, E., CHEN, Y.T., SCALAN, M.J., GOUT, I., KARBACH, J., ARAND, M., KNUTH, A., OLD, L.J.: A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J.Exp.Med., 1998 ; %20;187 ; 1349-1354.
19. ZENDMAN, A.J., RUITER, D.J., VAN MUIJEN,G.N. : Cancer/testis-associated genes: identification, expression profile, and putative function. J.Cell Physiol, 2003 ; 194 ; 272-288.